Early Detection is Critical

Detecting oral abnormalities early leads to more treatment options, potentially less invasive or radical treatments and better patient outcomes.

Introducing the VELscope® Vx Enhanced Oral Assessment System, which centers on a wireless, handheld scope that applies tissue fluorescence visualization to identify oral mucosal abnormalities early - often months or even years before they can be identified with the unassisted eye.

Approved by the FDA, Health Canada, and the World Health Organization, the award-winning VELscope® Vx is the world's most widely used adjunctive device for the discovery of:

• Viral, fungal and bacterial infections
• Inflammation from a variety of causes (lichen planus and lichenoid reactions, allergy to amalgam fillings, etc.)
• Squamous papillomas
• Salivary gland tumors
• Cancer and pre-cancer
• Other oral mucosal conditions